Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022

Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treatment. Some organizations double up as hybrid CDMOs and incubators.
They have their own pipelines, but they also partner with other companies to support and accelerate development.

Contract development and manufacturing organizations (CDMOs) and CROs are expanding organically and inorganically to provide end-to-end CGT services. More than 100 companies compete in the CGT CDMO marketplace globally, and most specialize in either cell therapy or gene therapy. Only a handful offer diversified services. CDMOs are increasingly distinguishing themselves from their competitors and have redefined themselves as contract research, development, and manufacturing organizations (CRDMOs) and have integrated themselves into companies’
value chains.

The Frost Radar™ reveals the market positioning of companies in an industry using their Growth and Innovation scores as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each of the companies in the Frost Radar™ based on their strengths, opportunities, and a small discussion on their positioning. Frost & Sullivan analyzes hundreds of companies in an industry and benchmarks them across 10 criteria on the Frost Radar™, where the leading companies in the industry are then positioned.


  • Strategic Imperative and Growth Environment
    • Strategic Imperative
    • Growth Environment
  • Cell and Gene Therapy Contract Development and Manufacturing Organizations Frost Radar
    • Frost Radar : Cell and Gene Therapy CDMOs
    • Frost Radar : Competitive Environment
  • Companies to Action
    • AGC Biologics
    • Catalent
    • Charles River Laboratories
    • Lonza
    • Merck KGaA
    • Minaris Regenerative Medicine
    • RoslinCT
    • Thermo Fisher Scientific
    • WuXi Advanced Therapies
  • Strategic Insights
  • Next Steps: Leveraging the Frost Radar to Empower Key Stakeholders
    • Significance of Being on the Frost Radar
    • Frost Radar Empowers the CEO's Growth Team
    • Frost Radar Empowers Investors
    • Frost Radar Empowers Customers
    • Frost Radar Empowers the Board of Directors
  • Frost Radar Analytics
    • Frost Radar : Benchmarking Future Growth Potential
    • Frost Radar : Benchmarking Future Growth Potential

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings